Halstead Michael

Average Profitability
67.15%
Insider Buys Quantity
2
Insider Buys Sum
$615,160.00
Insider Sells Quantity
31
Insider Sells Sum
$33.11M

Insider Activity of Halstead Michael

According to the SEC Form 4 filings, Halstead Michael, being in a position of

  1. President at Intra-Cellular Therapies, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 131827 shares for $9.72M,
    over all time since 2014-11-05, has bought 40000 shares for $615,160, and sold 793227 shares for $33.11M.

The largest purchase of all time was on 2014-11-06 and amounted to 26000 shares of Intra-Cellular Therapies, Inc. for $402,220.

The largest sale of all time was on 2021-12-21 and amounted to 176863 shares of Intra-Cellular Therapies, Inc. for $8.41M.

Biography of Halstead Michael

No biography is available at this moment.

2024-11-13SaleIntra-Cellular Therapies, Inc.
ITCI
President
18,714
0.0175%
$88.38$1.65M-3.59%
2024-11-12SaleIntra-Cellular Therapies, Inc.
ITCI
President
22,869
0.0216%
$89.12$2.04M-3.82%
2024-03-11SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
7,345
0.0076%
$65.97$484,537+12.32%
2024-03-07SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
13,132
0.0134%
$66.15$868,698+10.03%
2024-02-26SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
7,907
0.0079%
$69.53$549,784+2.3%
2024-02-02SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
11,860
0.012%
$66.42$787,719+8.4%
2024-01-11SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
50,000
0.0513%
$66.83$3.34M+7.04%
2023-03-13SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
7,344
0.0077%
$44.94$330,007+35.93%
2023-03-10SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
16,708
0.0172%
$43.10$720,086+38.64%
2023-02-24SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
7,906
0.0083%
$47.03$371,819+27.97%
2023-02-21SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
1,200
0.0013%
$48.76$58,508+29.6%
2023-02-21SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
11,139
0.0118%
$46.84$521,699+29.6%
2022-12-01SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
50,000
0.053%
$53.73$2.69M+3.46%
2022-02-24SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
7,906
0.0083%
$51.98$410,933-2.17%
2022-02-22SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
11,139
0.0122%
$55.40$617,100-3.92%
2022-01-10SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
19,639
0.0211%
$40.77$800,774+29.07%
2021-12-21SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
176,863
0.2148%
$47.56$8.41M+9.7%
2021-02-19SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
11,139
0.0137%
$39.24$437,133-4.23%
2021-01-11SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
19,638
0.0243%
$32.03$628,978+15.93%
2021-01-04SaleIntra-Cellular Therapies, Inc.
ITCI
EVP and General Counsel
16,160
0.0197%
$31.30$505,834+16.63%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.